Rodríguez-López Raquel, Gimeno-Ferrer Fátima, do Santos David Albuquerque, Ferrer-Bolufer Irene, Luján Carola Guzmán, Alcalá Otilia Zomeño, García-Banacloy Amor, Cogollos Virginia Ballesteros, Juan Carlos Sánchez
Laboratory of Molecular Genetics, Clinical Analysis Service, General Hospital Consortium of Valencia, Valencia, Spain.
Pediatrics Service, General Hospital Consortium of Valencia, Valencia, Spain.
Curr Genomics. 2022 Jul 5;23(3):147-162. doi: 10.2174/1389202923666220426093436.
Individuals with a phenotype of early-onset severe obesity associated with intellectual disability can have molecular diagnoses ranging from monogenic to complex genetic traits. Severe overweight is the major sign of a syndromic physical appearance and predicting the influence of a single gene and/or polygenic risk profile is extremely complicated among the majority of the cases. At present, considering rare monogenic bases as the principal etiology for the majority of obesity cases associated with intellectual disability is scientifically poor. The diversity of the molecular bases responsible for the two entities makes the appliance of the current routinely powerful genomics diagnostic tools essential. Clinical investigation of these difficult-to-diagnose patients requires pediatricians and neurologists to use optimized descriptions of signs and symptoms to improve genotype correlations. The use of modern integrated bioinformatics strategies which are conducted by experienced multidisciplinary clinical teams. Evaluation of the phenotype of the patient's family is also of importance. The next step involves discarding the monogenic canonical obesity syndromes and considering infrequent unique molecular cases, and/or then polygenic bases. Adequate management of the application of the new technique and its diagnostic phases is essential for achieving good cost/efficiency balances. With the current clinical management, it is necessary to consider the potential coincidence of risk mutations for obesity in patients with genetic alterations that induce intellectual disability. In this review, we describe an updated algorithm for the molecular characterization and diagnosis of patients with a syndromic obesity phenotype.
具有早发性严重肥胖且伴有智力障碍表型的个体,其分子诊断范围可从单基因到复杂遗传特征。严重超重是综合征身体外观的主要标志,在大多数情况下,预测单个基因和/或多基因风险概况的影响极其复杂。目前,将罕见的单基因基础视为大多数与智力障碍相关的肥胖病例的主要病因,在科学上是站不住脚的。导致这两种情况的分子基础的多样性使得应用当前常规强大的基因组学诊断工具成为必要。对这些难以诊断的患者进行临床调查,需要儿科医生和神经科医生使用对体征和症状的优化描述,以改善基因型相关性。由经验丰富的多学科临床团队采用现代综合生物信息学策略。对患者家族表型的评估也很重要。下一步包括排除单基因典型肥胖综合征,考虑罕见的独特分子病例和/或多基因基础。对新技术及其诊断阶段的应用进行适当管理,对于实现良好的成本/效率平衡至关重要。在当前的临床管理中,有必要考虑肥胖风险突变与导致智力障碍的基因改变患者之间的潜在重合。在这篇综述中,我们描述了一种用于具有综合征性肥胖表型患者的分子特征分析和诊断的更新算法。